Cao Zou

Dr. Cao Zou


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2023 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
ZLZirui Liu
Zirui Liu
HWHaocheng Wang
Haocheng Wang
ZYZhengkai Yang
Zhengkai Yang
YLYu Lu
Yu Lu
CZCao Zou
Cao Zou
Background: The presence of type 1 diabetes mellitus (T1DM) has been demonstrated to pose an increased risk for developing cardiovascular diseases (CVDs). However, the causal relationships between T1DM and CVDs remain unclear due to the uncontrolled confounding factors and reverse causation bias of the observational studies. Methods: Summary statistics of T1DM and seven CVDs from the largest available genome-wide association studies (GWAS) of European ancestry and FinnGen biobank were extracted for the primary MR analysis, and the analysis was replicated using UK biobank (UKBB) for validation. Three complementary methods: inverse variance weighted (IVW), weighted median, and MR-Egger were used for the MR estimates. The potential pleiotropic effects were assessed by MR-Egger intercept and MR-PRESSO global test. Additionally, multivariable MR (MVMR) analysis was performed to examine whether T1DM has independent effects on CVDs with adjustment of potential confounding factors. Moreover, a two-step MR approach was used to assess the potential mediating effects of these factors on the causal effects between T1DM and CVDs. Results: Causal effects of T1DM on peripheral atherosclerosis (odds ratio [OR] = 1.06, 95% confidence interval [CI]: 1.02–1.10; p = 0.002)] and coronary atherosclerosis (OR = 1.03, 95% CI: 1.01–1.05; p = 0.001) were found. The results were less likely to be biased by the horizontal pleiotropic effects (both p values of MR-Egger intercept and MR-PRESSO Global test > 0.05). In the following MVMR analysis, we found the causal effects of T1DM on peripheral atherosclerosis and coronary atherosclerosis remain significant after adjusting for a series of potential confounding factors. Moreover, we found that hypertension partly mediated the causal effects of T1DM on peripheral atherosclerosis (proportion of mediation effect in total effect: 11.47%, 95% CI: 3.23–19.71%) and coronary atherosclerosis (16.84%, 95% CI: 5.35–28.33%). We didn’t find significant causal relationships between T1DM and other CVDs, including heart failure (HF), coronary artery disease (CAD), atrial fibrillation (AF), myocardial infarction (MI) and stroke. For the reverse MR from CVD to T1DM, no significant causal relationships were identified. Conclusion: This MR study provided evidence supporting the causal effect of T1DM on peripheral atherosclerosis and coronary atherosclerosis, with hypertension partly mediating this effect.

27 March 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SZShasha Zhu
Shasha Zhu
WZWei Zhang
Wei Zhang
CXChunming Xu
Chunming Xu
JHJie Huang
Jie Huang
CZCao Zou
Cao Zou

20 March 2024 in Journal of Affective Disorders
Verified
Journal Article
Open access
ZLZirui Liu
Zirui Liu
HWHaocheng Wang
Haocheng Wang
ZYZhengkai Yang
Zhengkai Yang
YLYu Lu
Yu Lu
JWJikai Wang
Jikai Wang
CZCao Zou
Cao Zou
Mood swings is linked to a higher risk of cardiovascular diseases (CVDs). However, the causal relationships between them remain unknown. We conducted this Mendelian randomization (MR) analysis to evaluate the causal associations between mood swings (n = 373,733) and 5 CVDs, including CAD, MI, HF, AF, and stroke using summary data of large-scale genome-wide association studies (GWAS). FinnGen datasets validated the results. Various MR approaches, sensitivity analyses, multivariable MR (MVMR), and two-step MR mediation analyses were applied. The MR analysis revealed significant causal effects of mood swings on CAD (OR = 1.45, 95 % CI 1.24-1.71; P = 5.52e-6), MI (OR = 1.60, 95 % CI 1.32-1.95; P = 1.77e-6), HF (OR = 1.42, 95 % CI 1.18-1.71; P = 2.32e-4), and stroke (OR = 1.48, 95 % CI 1.19-1.83; P = 3.46e-4), excluding AF (P = 0.16). In the reverse MR analysis, no causal relationships were observed. The results were reproducible using FinnGen data. In the MVMR analysis, the causal effects of mood swings on CAD, MI, HF and stroke still remain significant after adjusting potential confounding factors including BMI, smoking and T2DM, but not for LDL and hypertension. Further mediation analysis indicated hypertension may mediate the causal pathways from mood swings to CAD (18.11 %, 95 % CI: 8.83 %-27.39 %), MI (16.40 %, 95 % CI: 7.93 %-24.87 %), HF (13.06 %, 95 % CI: 6.25 %-19.86 %), and stroke (18.04 %, 95 % CI: 8.73 %-27.34 %). Mood swings has a significant causal impact on the development of CAD, MI, HF, and stroke, partly mediated by hypertension.

22 May 2025 in Hereditas
Verified
Journal Article
Open access
ZLZirui Liu
Zirui Liu
RFRui Feng
Rui Feng
YXYing Xu
Ying Xu
MLMeili Liu
Meili Liu
HWHaocheng Wang
Haocheng Wang
CZCao Zou
Cao Zou
Background: Methylation of RNA is involved in many pathophysiological processes. The roles of N6-methyladenosine (m6A) and N7-methylguanosine (m7G) in heart failure (HF) have been established. However, the impact of 5-methylcytosine (m5C) on HF and its relationship with the immune microenvironment (IME) remains elusive. Methods: GSE141910 (200 HF, 166 NFDs) was used as training cohort. Focusing on 9 identified m5C differently expressed genes (DEGs), random forests (RF), LASSO logistic regression, and SVM-RFE were employed to identify hub genes. ROC curves were plotted to confirm the predictive value in diagnostic model. ScRNA-seq revealed cell-type-specific m5C regulator expression patterns and HF IME. Hub genes were validated using HF rat models after myocardial infarction (MI) through quantitative reverse-transcription PCR (qRT-PCR) and western blot (WB). Consensus clustering algorithms identified two m5C-related HF subtypes. Single-sample gene-set enrichment analysis (ssGSEA) and CIBERSORT deconvolution algorithm analyzed the IME in HF. Finally, we employed WGCNA and PPI network to find m5C associated key genes and their clinical significance in HF subgroups. Results: In HF samples, four m5C regulators (NSUN6, DNMT3A, DNMT3B and ALYREF) were greatly upregulated, while five (NOP2, NSUN3, NSUN7, DNMT1 and TRDMT1) were downregulated compared to NFDs in the training set. ALYREF positively correlated with activated NK cells and monocytes, whereas TRDMT1 and NSUN3 showed inverse correlations with these cells. Four hub genes were identified by machine-learning algorithms and all verified by validation model. Single-cell RNA-seq dataset GSE183852 examined the levels of 13 m5C regulators across 11 different cell types in HF. In vivo experiments including qRT-PCR and WB finally identified NSUN6 as the most remarkable regulator. The diagnostic model demonstrated excellent performance in distinguishing between HF and NFDs (AUC 0.869, 95%CI 0.832–0.906). The two m5C subtypes exhibited distinct modification patterns, immune cell infiltration, immune checkpoints, and HLA gene expression. Additionally, 138 differentially expressed genes were uncovered based on m5C subtypes, and GSEA revealed associations with key pathophysiological mechanisms of HF. By using WGCNA and PPI network, three m5C associated key genes (RPS21, RPL36 and RPS19) were identified significantly influencing cardiac function in clinical practice. Conclusion: HF diagnostic model is developed based on 4 robust m5C RNA modification biomarkers (DNMT3B, NOP2, NSUN6 and DNMT1). Two distinct m5C RNA modification patterns in HF are identified, illustrating different IME characteristics. Our findings underline the significance of m5C regulators in HF, offering new perspectives on HF mechanisms and potential diagnostic and therapeutic strategies.

1 January 2023 in The Tohoku Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
LLLan Liu
Lan Liu
SSSijia Sun
Sijia Sun
ZYZhengkai Yang
Zhengkai Yang
SZShasha Zhu
Shasha Zhu
CZCao Zou
Cao Zou
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.

8 February 2023 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
JZJiawei Zhou
Jiawei Zhou
CZChengchuang Zhan
Chengchuang Zhan
JZJing Zhou
Jing Zhou
CWChao Wei
Chao Wei
CZCao Zou
Cao Zou
Patients with secondary cardiac cancer occasionally show ST segment elevation that mimics acute coronary syndrome despite the absence of coronary artery occlusion. We herein describe a rare case of secondary cardiac cancer that presented with ST-segment elevation. An 82-year-old Chinese man was admitted to the hospital with chest discomfort. Electrocardiography (ECG) showed ST segment elevation in the precordial leads and low-voltage QRS complexes in limb leads without the development of Q waves. Unexpectedly, emergency coronary angiography showed no significant stenosis of the coronary arteries. However, fortunately, transthoracic echocardiography (TTE) revealed massive pericardial effusion and a mass at the apex of the ventricular myocardium. Coincidentally, contrast-enhanced chest computed tomography showed primary lung cancer in the left lower lobe, pericardial effusion, and myocardial metastasis at the ventricular apex. The pericardiac fluid contained blood with significantly increased CEA levels and exfoliated tumor cells. The lung histopathological report suggested squamous cell carcinoma. Two months later, the patient died. These findings suggested that the persistent ST-segment without the development of Q waves was associated with ventricular invasion by primary lung cancer and may indicate a poor prognosis. In conclusion, physicians should be aware of persistent ST-segment elevation mimicking myocardial infarction due to cardiac metastasis with a poor prognosis.